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Porcine reproductive and respiratory syndrome (PRRS) is an economically important swine disease that 
has devastated the swine industry worldwide. Vaccination with live attenuated vaccine or inactivated 
vaccine is the main treatment to control PRRS. However, the disadvantages such as virulence 
resumption of the attenuated vaccine and low immunogenicity of the inactivated vaccine call for a more 
efficient and safer genetically engineered vaccine. In this study, the structural protein GP5 of the PRRS 
virus (PRRSV), one of the major protective antigens which stimulates a protective immune response 
was selected to develop a genetically engineered subunit vaccine. In order to promote the immune 
reaction of the host to GP5, heat shock protein 70 (Hsp70) was selected as immuno-adjuvant to enhance 
PRRSV GP5 immunogenicity. The Hsp70 gene was amplified by PCR from attenuated Mycobacterium 
bovis, and the PRRSV GP5 gene was amplified by RT-PCR from the total RNA of PRRSV SCQ strain 
which was isolated, identified and maintained by the Animal Biotechnological Center, Sichuan 
Agricultural University, China. The fusion expressing plasmid pET32-GP5-Hsp70 was constructed and 
expressed in Escherichia coli BL21. Ni
2+
-chelating resin was used to purify the His-tagged fusion protein 
expressed under optimized expressing conditions. The rabbit anti-GP5-Hsp70 fusion protein antibody 
was made, and Western blot assay verified the successful expression of the fusion protein, making it 
possible for further investigation whether Hsp70 could improve the immunogenicity of the PRRSV GP5 
subunit vaccine, or evaluating the immunogenicity of the GP5-Hsp70 subunit vaccine. 
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Porcine reproductive and respiratory syndrome (PRRS) is 
caused by PRRS virus (PRRSV), a positive-sense single 
stranded enveloped RNA virus of the family Arteriviridae 
and the genus Arterivirus (Meulenberg 2000). PRRS has 
caused enormous financial losses to swine industry 
worldwide with clinical signs such as respiratory disease 
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(Tong et al., 2007). Especially, from 2006 till now, a  
highly pathogenic PRRSV spread widely in China and 
has given a serious problem to Chinese swine industry 
(Li et al., 2009). 
PRRSV is subject to heterogenesis and always co-
infects with other pathogens, such as Steptococcus suis, 
Haemophilus parasuis (H. parasuis), Mycoplasma 
hyopneumoniae, Actinobaccillus pleuropneumoniae, 
Salmonella spp., Pasteurella multocida, and swine 
influenza virus, which makes it more difficult to prevent 
and control (Groschup et al., 1993; Zeman et al., 1993). 
Vaccination is the most important way to  prevent  PRRS.  




Table 1. The primers of PRRSV GP5 gene and Hsp70 gene of M. bovis. 
  
Gene Primer Restriction enzyme 
PRRSV GP5 (upper) P1 5'-AATGGATCCCTCGCCAGCAGCGAC-3' 
PRRSV GP5 (lower) P2 5'-CCGAAGCTT AGGACGACCCCATTG -3' 
Hsp70 (upper) P3 5'-AATAAGCTTACCATGGCTC GTGCG-3' 








However, the traditional PRRSV vaccines such as 
modified live vaccine or killed vaccine showed low 
efficacy (Scortti et al., 2007; Okuda et al., 2008).  
PRRSV genome is approximately 15 kb in size and 
consists of nine open reading frames (ORFs), with each 
ORF partially overlapping with consecutive ORF, and 
performs its own biological function, respectively 
(Conzelmann et al., 1993; Thiel et al., 1993). ORF5 is an 
important structural protein gene, encoding the major 
envelope glycoside protein GP5. GP5 is extensively 
considered to be the binding protein of the virus receptor, 
and is one of the most important antigen proteins eliciting 
antibody response in PRRSV infection, so the GP5 gene 
is a good candidate for developing genetically engineered 
subunit vaccines (Pirzadeh and Dea, 1998). However, 
the GP5 protein itself has poor immunogenicity (Foss et 
al., 2002). 
Heat shock proteins (Hsps) are a group of highly 
conserved proteins, which are classified into Hsp90, 
Hsp70, Hsp60 and small Hsp families based on 
molecular size (Itoh et al., 1999). They play a significant 
role in protecting cells against various cellular stresses, 
such as heat, hypoxia, irradiation, oxidative stress and so 
on (Schroder et al., 2003; Atalay et al., 2009). They parti-
cipate in antigen processing, presentation and T cell 
activation in immune response process, stimulate a 
specific cytotoxic T lymphocyte (CTL) response, and 
contribute to tumor immunity, infection immunity and the 
pathology mechanisms of autoimmune diseases (Koets 
et al., 1999; Wong, 1999; Atay et al., 2009; Tsan and 
Gao, 2009). They are involved in protein translocation, 
new protein assembly and the prevention of protein 
aggregation (Mokrushin et al. 2004). Hsps, expressed by 
prokaryotes and eukaryotes and their action as molecular 
chaperones have brought more focus on their important 
biological functions ( Guerra et al., 2005; Jonak et al., 
2009). 
Among all Hsps, Hsp70 is the most conserved and 
widely studied. Hsp70 is mainly in the cytoplasm but also 
occurs in many cellular compartments (Itoh et al. 1999). 
There have been many reports on Hsp70 acting as 
potent immuno-adjuvant to enhance both innate and 
adaptive immune system (Prohaszka et al., 2002), and 
not only a good immuno-adjuvant but also a protective 
antigen (Li et al., 2009; Tsan and Gao, 2009). Therefore, 
Hsp70, performing as an immuno-adjuvant, gives hopes 
for development of an efficient and safe PRRSV genetic-
engineering subunit vaccine (Ye et al., 2004).  
The objective of this study was to construct a fusion 
vector with the PRRSV GP5 gene and the Mycobacterium 
bovis Hsp70 gene in pET-32a(+) plasmid, express the 
recombinant plasmid in Escherichia coli BL21, immunize 
the rabbit with the expressed fusion protein to prepare 




MATERIALS AND METHODS 
 
Virus, bacteria and plasmid  
 
The PRRSV SCQ strain was isolated, identified and maintained by 
the Animal Biotechnological Center, Sichuan Agricultural University, 
China. E. coli DH5α and BL21, pMD18-T Vector were purchased 
from TaKaRa Biotechnology Co. Ltd. (Dalian, China). The attenua-
ted strain of Mycobacterium bovis (M. bovis) was obtained from 
Disease Control Center of Ya'an City, Sichuan province, China. 
pET-32a(+) plasmid was maintained by Animal Biotechnological 





Trizol® Reagent was purchased from GIBCO BRL Company. High 
Pure RNA Isolation Kit was the production of Boehringer Mannheim 
Corporation. Myco DNAout Kit was provided by TIANDZ GENE 
Company. 2×Taq PCR Master Mixture, Ligation Mixture, RT-Kit, 
DNA Marker III Restriction enzymes BamHI, Hind III and Xhol I 
were provided by TaKaRa Biotechnology Co. Ltd. (Dalian, China). 




Primer design and sequencing 
 
Two pairs of primers were designed based on the ORF of Hsp70 
gene of the Mycobacterium tuberculosis (GenBank ID:BX248335) 
and GP5 gene (GenBank ID:DQ379479) of the PRRSV SCQ 
Strain. The upper (P1) and lower primer (P2) of GP5 gene included 
BamH Ⅰand Hind III enzyme digestion sites, respectively. In order 
to fuse Hsp70 gene at the end of GP5 gene, the termination codon 
of GP5 gene was deleted in the lower primer. The upper (P3) and 
lower primer (P4) of Hsp70 gene included HindIII and XhoI restrict-
tion enzyme digestion sites, respectively (Table 1). Primer synthesis 
and the sequencing of the target genes were executed by Shanghai 
Invitrogen Biotech Company, China. 
 
 
Amplification of target gene Hsp70 and construction of pMD18 
-Hsp70 plasmid 
 
The genome DNA of M. bovis was extracted using Myco DNAout 
Kit (TIANDZ GENE Company) as template. The full length of Hsp70  




gene of M. bovis was amplified by PCR with P3/ P4 primers. PCR 
amplification of Hsp70 gene was carried out in a reaction mixture of 
25 μl including 10.5 μl sterilized water, 12.5 μl 2×Taq PCR Master 
Mixture, 0.5 μl (20 μmol/l) of each primer (P3 and P4) and 1 μl 
template DNA. The thermal conditions and cycles were as follows: 
one cycle at 94°C for 5 min, followed by 30 cycles at 95°C for 1 
min, 56°C for 40 s and 72°C for 2 min, and a final extension at 72°C 
for 10 min. The PCR product was inserted into pMD18-T vector to 
construct pMD18-Hsp70 plasmid. The pMD18-Hsp70 plasmid was 
transformed into DH5α host bacteria and extracted from the 
bacteria, then identified by PCR with primers P3/P4 and by double-
digestion with restriction enzymes HindIII and XhoI, and also by 
sequencing of Hsp70 gene in the plasmid. The pMD18-Hsp70 
plasmid was kept at -20°C for use. 
 
 
Amplification of target gene PRRSV GP5 and construction of 
pMD18-GP5 plasmid 
 
Virus RNA was extracted from PRRSV SCQ strain using Trizol® 
Reagant (GIBCO BRL Company) and purified with High Pure RNA 
Isolation Kit (Boehringer Mannheim Corporation). Reverse 
transcription (RT) was conducted with random primers using 
reverse transcriptase kit (TaKaRa Biotechnology Co. Ltd., Dalian, 
China), and PCR was carried out in a reaction mixture as above 
except for different primers (P1and P2) and cDNA template. The 
thermal conditions were as follows: one cycle at 94°C for 5 min, 
followed by 30 cycles at 95°C for 30 s, 55°C for 40 s and 72°C for 
30 s, and a final extension at 72°C for 10 min.  
PCR product was detected and purified. The recombinant 
pMD18-GP5 plasmid was identified by PCR with primers P1/P2, 
double-digestion with restriction enzymes BamHI and HindIII, and 
also by sequencing.  
 
 
Construction of fusion expressed plasmid pET32-GP5-Hsp70 
 
pMD18-GP5 and pET-32(α+) plasmids were both double-digested 
by BamHI and HindIII and purified. The GP5 gene was inserted into 
the pET-32(α+) plasmid and transformed into DH5α host bacteria. 
The transformed DH5α bacteria were cultured and the recombinant 
plasmid was identified by PCR and double-digestion. The 
recombinant plasmid was named as pET32-GP5, and kept at -20°C 
until use. 
The pMD18-Hsp70 and pET32-GP5 plasmids were both double-
digested with the restriction enzymes HindIII and Xhol and purified. 
A new recombinant plasmid, named pET32-GP5-Hsp70, was con-
structed by inserting Hsp70 gene into pET32-GP5 plasmid. The 
pET32-GP5-Hsp70 was digested with three pairs of restriction 
enzyme (BamHI /XholI, BamHI/HindIII, Hind III/XholI). PET32-GP5-




Expression, purification and analysis of fusion protein GP5-
Hsp70 
 
The fusion gene GP5-Hsp70 was expressed following the con-
ventional protocol to obtain the fusion protein GP5-Hsp70. Briefly, 
an overnight culture of BL21 containing the recombinant plasmid 
pET-32-GP5-Hsp70 was refreshed with LB broth containing 50 
mg/L ampicillin, when the culture grew to an optical density (OD) of 
0.6 at 600 nm, the cells were induced with 1 mmol/L isopropyl-β-D-
thiogalactoside (IPTG) for 4 h. Then, the cells were harvested by 
centrifugation at 13,000 rpm for 1 min at 4°C. The cell sediment 
was collected and resuspended with sterilized H2O and equal 
volume of 2×SDS-PAGE (sodium dodecyl sulfate-polyacrylamide 





detect the fusion protein. Different induction time, IPTG 
concentration and induction temperature were compared to study 
the optimal expressing conditions.  
To detect the solubility of the fusion protein GP5-Hsp70, BL21 
containing the recombinant plasmid pET32-GP5-Hsp70 was 
induced by IPTG following the optimal expressing conditions as 
optimized above. Cells were harvested by centrifugation at 13,000 
rpm for 1 min at 4°C, resuspended in 20 mmol/l Tris-HCl (pH 8.0), 
antalzyme was added with the concentration of 1 mg into 1 ml BL21 
solution, incubated at 37°C for 30 min, conserved at -20°C, frozen 
thawed after consolidation and repeated twice. The mixture was 
broken by ultrasonic wave on ice. The total lysate was divided into 
soluble and insoluble fractions by centrifugation at 13,000 rpm for 5 
min at 4°C. The soluble and insoluble fractions were analyzed by 
12% SDS-PAGE, and visualized using Coomassie Brilliant Blue.  
Ni
2+ 
chelating resin (200 μl), equilibrated with 5 ml of sterile 
deionized H2O, 2 ml of 50 mmol/l Na2SO4, and 5 ml of PBS (pH 
7.2), was used to purify protein from the expressing cells broken by 
ultrasonic wave with the conventional protocol mentioned above. 
The supernatant was passed through the column, followed by 
washing the column with 5 ml PBS (pH 7.2) and 5 ml wash buffer 
(20 mmol/l imidazole in PBS), respectively. The target protein was 
then eluted with 2 ml of elution buffer (200 mmol/l imidazole in 
PBS). The eluted fractions were detected by 12% SDS-PAGE. 
 
 
Preparation of rabbit anti-GP5-Hsp70 antibody and Western 
blot analysis of protein GP5-Hsp70  
 
The purified fusion protein GP5-Hsp70 was used to immunize white 
rabbits. All animal manipulations were approved by Sichuan 
Province Institutional Animal Care and Use Committee. The rabbits 
were immunized with 0.75 mg GP5-Hsp70 protein in complete 
Freund’s adjuvant (Kothari et al., 2006; Liang et al., 2009). The 
booster immunization were performed weekly for 3 times after the 
first vaccination with 0.75 mg GP5-Hsp70 protein in incomplete 
Freund’s adjuvant, then rabbit sera were collected at 10 days after 
the last immunization. The sera were tested by Western blot using 
the purified fusion protein GP5-Hsp70 as antigen (Done and Paton, 
1995).  
Western blot was carried out according to the standard 
procedure. Protein GP5-Hsp70 was separated by SDS-PAGE with 
12% gel and electrophoretically transferred to a nitrocellulose 
membrane. The nitrocellulose membrane was then blocked over-
night at 4°C with 10% skimmed milk in TBS (Tris buffered saline 
with 0.1%Tween 20, pH 8.0). After washing with TBS, the mem-
brane was incubated for 60 min with the rabbit anti fusion protein 
GP5-Hsp70 antiserum at 4°C. The membrane was washed and 
incubated for 60 min with horseradish peroxidase-conjugated goat 
anti-rabbit antibody. After further washing, bands were visualized 
using diaminobenzidin (DAB) colour developing reagents. 
 
 
RESULTS AND DISCUSSION 
 
 
Construction of the pMD18-Hsp70 plasmid 
 
The Hsp70 gene PCR fragment was approximately 2000 
bp (Figure 1A), coinciding with its theoretical size. The 
results of pMD18-Hsp70 positive recombinant plasmid 
PCR amplification and double-digestion with restriction 
enzymes HindIII /Xhol are shown in Figure 1B. The 
sequence of PCR fragment was 98.6% identity with the 
sequence of M. bovis in the GenBank. The pMD18- 
Hsp70 plasmid was successfully constructed.  






Figure 1. PCR amplification of M. bovis Hsp70 gene and identification of the 
recombination vector pMD18-Hsp70. A. Result of PCR amplification for M. 
bovis Hsp70 gene. Lane M, DNA marker 2,000; Lane 1, the amplified product 
of M. bovis Hsp70 (about 2,000 bp). B. Identification of the recombination 
vector pMD18-Hsp70 by PCR and restriction enzymes digestion. Lane M, DNA 
marker 4,500; lane 1, the amplified product of M. bovis Hsp70 (about 2,000bp) 
from the recombinant plasmid pMD18-Hsp70; lane 2, the recombinant plasmid 
pMD18-Hsp70 digested with HindIII and XhoI (the PCR products with about 




Construction of pMD18-GP5 plasmid 
 
The acquired PRRSV SCQ GP5 gene was approximately 
530 bp (Figure 2A), coinciding with its theoretical size. 
The pMD18-GP5 plasmid PCR amplified from recom-
binant bacteria with primer pairs P1/P2 showed a single 
objective product of about 530 bp in site (Figure 2B), and 
the pMD18-GP5 plasmid double-digested with restriction 
enzymes BamHI and HindIII showed the objective band 
at 530 bp site as expected (Figure 2C). The sequence of 
GP5 PCR fragment was 99.7% identity with the 
sequence of PRRSV SCQ GP5 in the GenBank. The 
GP5 gene was successfully cloned into pMD18-T vector. 
 
 
Construction of pET32-GP5-Hsp70 
 
Double digested GP5 gene (BamHI and Hind III) form 
pMD18-GP5 was inserted into the expressing plasmid 
pET-32a(+), named pET32-GP5. Double digested Hsp70 
gene (HindIII and Xhol) from pMD18-Hsp70 was inserted 
into plasmid pET32-GP5. PCRs with two pairs of primers 
(P1 and P4, P3 and P4) and double digestion with three 
pairs of restriction enzymes (BamHI and HindIII, BamHI 
and Xhol, HindIII and Xhol) showed the successful 
construction of pET32-GP5-Hsp70 (Figure 3A and B). 
Sequence analysis also confirmed the expected GP5-
Hsp70 sequence. 
Expression of fusion protein GP5-Hsp70 
 
The recombinant plasmid pET32-GP5-Hsp70 was 
expressed in host bacteria E. coli BL21. SDS-PAGE 
result showed that the molecular weight of the target His-
tagged fusion protein was about 110 kDa (containing 
6×histidine tag sequences), which was consistent with 
the theoretical value (Figure 4A). Several expression con-
ditions were experimented, when the cell density for 
pET32-GP5-Hsp70 induction was at OD600 of 0.6, and the 
optimal protein expression occurred at 4 h post-induction 
with 0.5 mmol/l IPTG at 30°C (Figure 4B, C and D), and 
the fusion protein appeared mainly in the pellet of the 









-resin purified his-tagged GP5-Hsp70 protein was 
detected at 110 kD site by  SDS-PAGE  showing a single 
objective band (Figure 5A). The titer of rabbit anti-GP5-
Hsp70 antibody was 1:2
5
 when the antibody was serial 
diluted and detected with agarose gel double diffusion 
method. When the purified fusion protein reacted with 
rabbit anti-GP5-Hsp70 antibody by Western blot, the 
antibody recognized the GP5-Hsp70 fusion protein at the 
site of appropriate molecular weight (Figure 5B). 
     
A B 






Figure 2. PCR amplification of PRRSV GP5 gene and identification of the recombination vector pMD18-Hsp70. A. Result of PCR 
amplification for PRRSV GP5 gene. Lane M, DNA marker 4,500; lane 1, the amplified product of PRRSV GP5 (about 530 bp); B. 
Identification of the recombinant bacteria by PCR. lane M, DNA marker 4,500; lane 1, the false amplified product of PRRSV GP5 from one 
selected recombinant bacteria; lanes 2, 3 and 4, the correct amplified product of PRRSV GP5 from three selected recombinant bacteria (the 
PCR products with about 530 bp); C. Identification of the recombination vector pMD18-GP5 by restriction enzymes digestion. Lane M, DNA 
marker 4,500; lane 1, the recombinant plasmid pMD18-GP5 was digested with BamHI and HindIII (the PCR products with about 530 bp and 






Figure 3. PCR amplification of PRRSV GP5 gene and M. bovis Hsp70 gene from the recombination vector pET32-GP5-Hsp70 plasmid, 
respectively, and identification of the recombination vector pET32-GP5-Hsp70 plasmid. A. Result of PCR amplification for PRRSV GP5 
gene and M. bovis Hsp70 gene. Lane M, DNA marker 4,500; lane 1, the amplified product of PRRSV GP5 gene (about 530 bp); lane 2, 
the amplified product of M. bovis Hsp70 (about 2,000 bp). B. Identification of the recombination vector pET32-GP5-Hsp70 by restriction 
enzymes digestion. lane M, DNA marker 4,500; lane 1, the recombinant plasmid pET32-GP5-Hsp70 was digested with BamHI and Xhol 
(the PCR product of PRRSV GP5 gene plus M. bovis Hsp70 gene was about 2, 530 bp and the pET32(a)+ vector was about 4,700 bp); 
lane 2, the recombinant plasmid pET32-GP5-Hsp70 digested with HindIII and XhoI (the PCR product of M. bovis Hsp70 gene was about 
2, 000 bp and the pET32(a)+ vector plus PRRSV GP5 gene was about 5, 230 bp); lane 3, the recombinant plasmid pET32-GP5-Hsp70 
digested with BamHI and Hind III (the PCR product of PRRSV GP5 gene was about 530 bp and the pET32(a)+ vector plus M. bovis 
Hsp70 gene was about 6,700 bp) . 
     A B 
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Figure 4. The optimization analysis of the expression conditions of the pET32a-GP5-Hsp70 protein in E. coli BL21. A. the pET32a-GP5-
Hsp70 protein was expressed in E. coli BL21 host strain. M, Protein molecular weight marker; lanes 1 and 4, the pET32a-GP5-Hsp70 before 
induction; lanes 2, 3, 5 and 6, the pET32a-GP5-Hsp70 after induction by 0.5 mmol/l IPTG for 4 h in E. coli BL21 (about 110 kDa). B. Effect of 
different time of the pET32a-GP5-Hsp70 protein in BL21. M, Protein marker; lanes 1 to 6, the pET32a-GP5-Hsp70 protein was expressed 
respectively for 1, 2, 3, 4, 5 and 6 h after induction with 0.5 mmol/l IPTG. C. Production of recombinant plasmid pET32a-GP5-Hsp70 from 
BL21 in different IPTG concentrations. M, Protein marker; lanes 1 to 4, the pET32a-GP5-Hsp70 protein was expressed respectively after 
induction with 0.3, 0.4, 0.5 and 0.6 mmol/l IPTG. D. Effect of different temperature of the pET32a-GP5-Hsp70 protein in BL21. M: Protein 
marker; Lanes 1 to 5, the pET32a-GP5-Hsp70 protein after induction at 20, 25, 30, 37 and42°C; E. Solubility identification of the pET32a-
GP5-Hsp70 protein; lane M, protein marker; lanes 1 and 2, sedimentation of induced transformed bacteria cracked by ultrasonic vibration 
showed that the pET32a-GP5-Hsp70 protein was expressed in the form of inclusion body; lanes 3 and 4, supernatants of induced 






Figure 5. SDS-PAGE of the purified pET32a-GP5-Hsp70 protein and Western blotting 
analysis. A. The SDS-PAGE analysis of the purified pET32a-GP5-Hsp70 protein. Lane 1, 
protein marker; lanes 2 to 3, the recombinant protein was purified by the Ni
2+
-NTA 
agarose gel. B. The immunogenicity of the recombinant pET32a-GP5-Hsp70 protein was 
analyzed by Western blotting with the rabbit anti-pET32a-GP5-Hsp70 serum. The 





PRRS is difficult to be controlled. The best way to control 
PRRS is to apply effective vaccine. In this study, we suc-
cessfully constructed and prokaryotic-expressed the 
fusion gene PRRSV GP5 and M. bovis Hsp70. The 
purified fusion protein was used to immunize the rabbit 
and produced specific antibody confirming the develop-
ment of effective subunit vaccine of PRRS. 
Poor immunogenicity and weak cross protection of 
PRRSV vaccines are the main issues in PRRSV immune-
zation. The utilization of vaccine adjuvants could improve 
vaccine immunogenicity (Royaee et al., 2004; Li et al., 
2009). Hsp70 has attracted much interest for its potential 
in enhancing immunogenicity (Li et al., 2007; Zhang et 
al., 2007). In this study, we successfully fused the most 
important PRRSV antigen coding gene GP5 with Hsp70 
gene from M. bovis, constructed and expressed fusion 
protein GP5-Hsp70. The efficiency of fusion protein GP5-
Hsp70 in enhancing immunogenicity, cell mediated immunity 
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